This article explores the impact of cultural influences and stigma on healthcare in the Asia-Pacific region. It examines how cultural stigma affects disease management and offers best practices to reduce stigma, promoting a more inclusive and supportive healthcare ecosystem.
Culture significantly influences healthcare behaviours across the globe, including in the Asia-Pacific (APAC) region, shaping how individuals perceive, manage, and seek treatment for illnesses. Traditional practices, societal norms, and stigma all play crucial roles in disease prevalence and management, offering both opportunities and challenges for pharmaceutical companies.
Across APAC, traditional medicine remains deeply embedded in healthcare. Traditional Chinese and Korean Medicine (TCM/TKM) emphasizes balance, with herbal remedies and acupuncture widely used for chronic conditions like diabetes and cancer. In Japan, the emphasis on harmony and hierarchy shapes a physician-driven healthcare system, where patient engagement remains limited.
Stigma is a pervasive challenge affecting healthcare access and treatment adherence across APAC. Chronic conditions such as diabetes, cancer, and mental health disorders are often viewed as personal or familial failures. This leads to concealment and reluctance to seek medical help, particularly in cultures that emphasize societal harmony and family reputation.
In this white paper, we will discuss examples of cultural stigma and how to break the cycle to improve disease management. We will also explore case studies on how companies can create meaningful impact by embracing cultural sensitivities to improve health outcomes and establish trust with their patients.
Click here to read the full article.
Get in touch: